OXON’s COVID-19 Research Programme
OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors
OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.
OXON will be supporting the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia on August 24-28, 2019.